Evidence map›Paper›PMID 38776107›Full record

ArticleTranslational vision science & technology2024

Design and Biocompatibility of a Novel, Flexible Artificial Cornea.

Gavin Li, Anthony J Aldave, Guillermo Amescua, Kathryn A Colby, Maria S Cortina, Jose de la Cruz, Jean-Marie A Parel, Thomas B Schmiedel, Esen Karamursel Akpek

Abstract read
In one paragraph

Article in Translational vision science & technology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gavin LiThe Ocular Surface Disease Clinic, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Anthony J AldaveStein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Guillermo AmescuaBascom Palmer Eye Institute, University of Miami-Miller School of Medicine, Miami, FL, USA.
Kathryn A ColbyDepartment of Ophthalmology at New York University Grossman School of Medicine, New York University, NY, USA.
Maria S CortinaIllinois Eye and Ear Infirmary, University of Illinois, Chicago, IL, USA.
Jose de la CruzIllinois Eye and Ear Infirmary, University of Illinois, Chicago, IL, USA.
Jean-Marie A ParelBascom Palmer Eye Institute, University of Miami-Miller School of Medicine, Miami, FL, USA.
Thomas B SchmiedelInnovation Center of Excellence, W. L. Gore & Associates, Inc., Newark, DE, USA.
Esen Karamursel AkpekThe Ocular Surface Disease Clinic, The Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We sought to introduce the materials, design, and biocompatibility of a flexible and suturable artificial corneal device. Methods: Single-piece, fully synthetic, optic-skirt design devices were made from compact perfluoroalkoxy alkane. The skirt and the optic wall surfaces were lined with a porous tissue ingrowth material using expanded polytetrafluoroethylene. Full-thickness macroapertures around the skirt perimeter were placed to facilitate nutrition of the recipient cornea. Material properties including the skirt's modulus of elasticity and bending stiffness, optic light transmission, wetting behavior, topical drug penetrance, and degradation profile were evaluated. Results: The final prototype suitable for human use has a transparent optic with a diameter of 4.60 mm anteriorly, 4.28 mm posteriorly, and a skirt outer diameter of 6.8 mm. The biomechanical and optical properties of the device closely align with the native human cornea with an average normalized device skirt-bending stiffness of 4.7 kPa·mm4 and light transmission in the visible spectrum ranging between 92% and 96%. No optical damage was seen in the 36 devices tested in fouling experiments. No significant difference was observed in topical drug penetrance into the anterior chamber of the device implanted eye compared with the naïve rabbit eye. Conclusions: The flexibility and biocompatibility of our artificial cornea device may offer enhanced tissue integration and decreased inflammation, leading to improved retention compared with rigid keratoprosthesis designs. Translational Relevance: We have developed a fully synthetic, flexible, suturable, optic-skirt design prototype artificial cornea that is ready to be tested in early human feasibility studies.

Indexed as

Biocompatible MaterialsCorneaMaterials TestingProsthesis DesignAnimalsHumansRabbitsBiocompatible Materials

Identifiers

PMID38776107
PMCPMC11127488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.